A pivotal, randomized, cross-over, comparative pharmacokinetic study comparing ZTlido (lidocaine patch 1.8%) with Versatis (lidocaine medicated plaster 5%) in healthy subjects.
Phase of Trial: Phase III
Latest Information Update: 28 Feb 2018
At a glance
- Drugs Lidocaine (Primary) ; Lidocaine (Primary)
- Indications Postherpetic neuralgia
- Focus Pharmacokinetics
- 28 Feb 2018 Results presented in a Sorrento Therapeutics Media Release.
- 05 Feb 2018 According to a Scilex Pharmaceuticals media release, MAA decision for ZTlido topical lidocaine system in the Europe is anticipated by year end 2018.
- 13 Jan 2017 New trial record